Research Progress of Traditional Chinese Medicine Monomer Inhibiting Metastatic Colonization of Ovarian Cancer Cells Based on Cell Biology
Ovarian cancer, a frequently occurring gynecological malignancy with a poor prognosis and a 5-year survival rate below 45%, often progresses due to metastatic colonization. This review highlights the potential of traditional Chinese medicine (TCM) monomers as anticancer agents that inhibit the metas...
Saved in:
| Main Authors: | Meng-Ya Wang BMed, Cheng-Xin Zhang MMed, Yu Wang MMed, Ying Guo MD, PhD, Fang Shen MD, PhD, Fang-Yuan Liu MD, PhD, Feng-Juan Han MD, PhD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-06-01
|
| Series: | Integrative Cancer Therapies |
| Online Access: | https://doi.org/10.1177/15347354251344953 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Chinese Medicine on Postoperative Rehabilitation of Non-small Cell Lung Cancer (NSCLC), a Randomized Controlled Study
by: Yifeng Gu MD, et al.
Published: (2025-01-01) -
Clinicopathological Characteristics and Prediction of Postoperative Mortality Risk in Patients with Non-metastatic Sarcomatoid Renal Cell Carcinoma
by: Lian Fang MD, et al.
Published: (2025-08-01) -
GuBenPeiYuan Formula Inhibits Lung Cancer Metastasis by Suppressing Myeloid-Derived Suppressor Cells and Related Immune Cells
by: Yizhao Du MD, et al.
Published: (2025-04-01) -
Phase 2 Trial of Combination Radiotherapy and Pembrolizumab Plus Chemotherapy in Patients With Previously Untreated Metastatic NSCLC: NJLCG 1902
by: Yoko Tsukita, MD, PhD, et al.
Published: (2025-05-01) -
Pilomatrixoma of the parotid region: A benign tumor mimicking metastatic cutaneous squamous cell carcinoma
by: Nikita Grieder, MD, et al.
Published: (2025-04-01)